33 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Atf3tm1.1Hai/Atf3tm1.1Hai Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * FVB/N	decreased metastatic potential	J:201626
Atf3tm1.2Kitab/Atf3tm1.2Kitab Tg(Pdx1-cre)89.1Dam/0 involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA	abnormal hypothalamus physiology	J:231262
	abnormal sympathetic nervous system physiology	J:231262
	abnormal white adipose tissue physiology	J:231262
	abnormal white fat cell morphology	J:231262
	decreased abdominal adipose tissue amount	J:231262
	decreased body weight	J:231262
	decreased circulating glucose level	J:231262
	decreased epididymal fat pad weight	J:231262
	decreased food intake	J:231262
	decreased inguinal fat pad weight	J:231262
	decreased subcutaneous adipose tissue amount	J:231262
	decreased white adipose tissue amount	J:231262
	normal endocrine/exocrine gland phenotype	J:231262
	normal homeostasis/metabolism phenotype	J:231262
	improved glucose tolerance	J:231262
	increased basal metabolism	J:231262
	increased body temperature	J:231262
	increased carbon dioxide production	J:231262
	increased energy expenditure	J:231262
	increased insulin sensitivity	J:231262
	increased oxygen consumption	J:231262
	increased respiratory quotient	J:231262
Atf3tm1Dron/Atf3tm1Dron B6.129X1-Atf3tm1Hai	abnormal pancreatic islet morphology	J:91595
Atf3tm1Dron/Atf3tm1Dron involves: 129X1/SvJ * C57BL/6	abnormal T-helper 2 physiology	J:140112
	decreased IgG2a level	J:140112
	decreased metastatic potential	J:201626
	increased interleukin-4 secretion	J:140112
	increased interleukin-5 secretion	J:140112
	increased interleukin-13 secretion	J:140112
	lung inflammation	J:140112
	normal neoplasm	J:201626
Atf3tm2b(EUCOMM)Wtsi/Atf3tm2b(EUCOMM)Wtsi C57BL/6N-Atf3tm2b(EUCOMM)Wtsi/H	abnormal retina morphology	J:211773
	decreased locomotor activity	J:211773